Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.

Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.

Item
http://www.wikidata.org/entity/Q38916710
The Natural Occurring Compounds Targeting Endoplasmic Reticulum StressDengue-induced autophagy, virus replication and protection from cell death require ER stress (PERK) pathway activationE-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.Calpain 1 regulates TGF-β1-induced epithelial-mesenchymal transition in human lung epithelial cells via PI3K/Akt signaling pathway.Comparative proteomic analysis of rats subjected to water immersion and restraint stress as an insight into gastric ulcers.Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain-mediated C/EBPβ and NFκB cleavage.Honokiol targets mitochondria to halt cancer progression and metastasis.Immunogenic Apoptotic Cell Death and Anticancer Immunity.Honokiol inhibits bladder cancer cell invasion through repressing SRC-3 expression and epithelial-mesenchymal transition.Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin.
P2860

Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.

Item
http://www.wikidata.org/entity/Q38916710
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Honokiol confers immunogenicit ...... ial-to-mesenchymal transition.
@en
type
label
Honokiol confers immunogenicit ...... ial-to-mesenchymal transition.
@en
prefLabel
Honokiol confers immunogenicit ...... ial-to-mesenchymal transition.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Honokiol confers immunogenicit ...... ial-to-mesenchymal transition.
@en
P2093
P2860
P304
P31
P356
10.1016/J.MOLONC.2014.12.009
P433
P478
P50
P577
P5875
P698
P932